Automated Prostate Gland Segmentation in MRI Using nnU-Net

Purpose: Accurate segmentation of prostate cancer on magnetic resonance (MR) images is crucial for planning image-guided interventions such as targeted biopsies, cryoablation, and radiotherapy. However, subtle and variable tumour appearances, differences in imaging protocols, and limited expert availability make consistent interpretation difficult. While automated methods aim to address this, they rely on large expertly-annotated datasets that are often inconsistent, whereas manual delineation remains labour-intensive. This work aims to bridge the gap between automated and manual segmentation through a framework driven by user-provided point prompts, enabling accurate segmentation with minimal annotation effort. Methods: The framework combines reinforcement learning (RL) with a region-growing segmentation process guided by user prompts. Starting from an initial point prompt, region-growing generates a preliminary segmentation, which is iteratively refined through RL. At each step, the RL agent observes the image and current segmentation to predict a new point, from which region growing updates the mask. A reward, balancing segmentation accuracy and voxel-wise uncertainty, encourages exploration of ambiguous regions, allowing the agent to escape local optima and perform sample-specific optimisation. Despite requiring fully supervised training, the framework bridges manual and fully automated segmentation at inference by substantially reducing user effort while outperforming current fully automated methods. Results: The framework was evaluated on two public prostate MR datasets (PROMIS and PICAI, with 566 and 1090 cases). It outperformed the previous best automated methods by 9.9% and 8.9%, respectively, with performance comparable to manual radiologist segmentation, reducing annotation time tenfold.

Automated 3D segmentation of prostate lesions from biparametric MRI (bp-MRI) is essential for reliable algorithmic analysis, but achieving high precision remains challenging. Volumetric methods must combine multiple modalities while ensuring anatomical consistency, but current models struggle to integrate cross-modal information reliably. While vision-language models (VLMs) are replacing the currently used architectural designs, they still lack the fine-grained, lesion-level semantics required for effective localized guidance. To address these limitations, we propose a new multi-encoder U-Net architecture incorporating three key innovations: (1) an alignment loss that enhances foreground text-image similarity to inject lesion semantics; (2) a heatmap loss that calibrates the similarity map and suppresses spurious background activations; and (3) a final-stage, confidence-gated multi-head cross-attention refiner that performs localized boundary edits in high-confidence regions. A phase-scheduled training regime stabilizes the optimization of these components. Our method consistently outperforms prior approaches, establishing a new state-of-the-art on the PI-CAI dataset through enhanced multi-modal fusion and localized text guidance. Our code is available at https://github.com/NUBagciLab/Prostate-Lesion-Segmentation.

Many diagnostic and therapeutic clinical tasks for prostate cancer increasingly rely on multi-parametric MRI. Automating these tasks is challenging because they necessitate expert interpretations, which are difficult to scale to capitalise on modern deep learning. Although modern automated systems achieve expert-level performance in isolated tasks, their general clinical utility remains limited by the requirement of large task-specific labelled datasets. In this paper, we present ProFound, a domain-specialised vision foundation model for volumetric prostate mpMRI. ProFound is pre-trained using several variants of self-supervised approaches on a diverse, multi-institutional collection of 5,000 patients, with a total of over 22,000 unique 3D MRI volumes (over 1,800,000 2D image slices). We conducted a systematic evaluation of ProFound across a broad spectrum of $11$ downstream clinical tasks on over 3,000 independent patients, including prostate cancer detection, Gleason grading, lesion localisation, gland volume estimation, zonal and surrounding structure segmentation. Experimental results demonstrate that finetuned ProFound consistently outperforms or remains competitive with state-of-the-art specialised models and existing medical vision foundation models trained/finetuned on the same data.